We discuss the current evidence for both benefit and harm of antihypertensive treatment in people with dementia. We conclude that there is a lack of evidence to support the claim that there is an increased risk of cerebral hypoperfusion with antihypertensive treatment in dementia, and that there is growing evidence which refutes this claim.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581244 | PMC |
http://dx.doi.org/10.1177/0271678X231179421 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!